Skip to content

   Pharma Publications

Neuropsychopharmacology
  • BNST PKCδ neurons are activated by specific aversive conditions to promote anxiety-like behavior
    Published on 2023-03-19
    3 years ago
  • Oxytocin effects on amygdala reactivity to angry faces in males and females with antisocial personality disorder
    Published on 2023-03-19
    3 years ago
  • In Memoriam—Robert M. A. Hirschfeld, MD, MSc
    Published on 2023-03-19
    3 years ago
  • Pathways link environmental and genetic factors with structural brain networks and psychopathology in youth
    Published on 2023-03-16
    3 years ago
  • Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice
    Published on 2023-03-16
    3 years ago
  • Psychedelics: preclinical insights provide directions for future research
    Published on 2023-03-16
    3 years ago
  • The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial
    Published on 2023-03-15
    3 years ago
« Previous 1 … 133 134 135 136 137 … 143 Next »
Journal of Psychopharmacology
  • Adjunctive minocycline for major mental disorders: A systematic review
    Published on 2019-07-11
    7 years ago
  • Histone deacetylases inhibitor trichostatin A reverses anxiety-like symptoms and memory impairments induced by maternal binge alcohol drinking in mice
    Published on 2019-07-11
    7 years ago
  • Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
    Published on 2019-07-11
    7 years ago
  • Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia
    Published on 2019-07-11
    7 years ago
  • Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
    Published on 2019-07-11
    7 years ago
  • Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model
    Published on 2019-07-10
    7 years ago
  • Differential rewarding effects of electrical stimulation of the lateral hypothalamus and parabrachial complex: Functional characterization and the relevance of opioid systems and dopamine
    Published on 2019-07-08
    7 years ago
« Previous 1 … 133 134 135 136 137 … 150 Next »
European Neuropsychopharmacology
  • P.851Differences in healthcare resource utilization across oral atypical antipsychotic treatments in patients with schizophrenia
    Published on 2020-11-25
    6 years ago
  • P.829Clinical characteristics of schizophrenia offspring, children diagnosed with attention deficit hiperactivity disorder and healthy controls
    Published on 2020-11-25
    6 years ago
  • P.855Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: pooled analysis of double-blind, placebo-controlled 6-week studies
    Published on 2020-11-25
    6 years ago
  • P.830A systematic review of antidepressant use in patients with delusional disorder: when and how?
    Published on 2020-11-25
    6 years ago
  • P.856Evidence-based psychoeducational program in first psychotic episode patients
    Published on 2020-11-25
    6 years ago
  • P.831Trajectories of suicidal ideation after a first-episode psychosis: a growth mixture modeling approach
    Published on 2020-11-25
    6 years ago
  • P.857Cognitive reserve in child and adolescent offspring of patients diagnosed with schizophrenia or bipolar disorder
    Published on 2020-11-25
    6 years ago
« Previous 1 … 133 134 135 136 137 … 168 Next »

   Pharma Pub